Finnish Institute for Health and Welfare

Finnish Biobanks (FINBB) Partners with TriNetX to Increase Clinical and Biomedical Trials in Finland

Retrieved on: 
Tuesday, June 14, 2022

The goal of the collaboration is to connect major Finnish healthcare organizations to FINBB's national collaborative known as the Fingenious service network, and to attract more research projects as well as increase the number of clinical trials in Finland.

Key Points: 
  • The goal of the collaboration is to connect major Finnish healthcare organizations to FINBB's national collaborative known as the Fingenious service network, and to attract more research projects as well as increase the number of clinical trials in Finland.
  • "We believe that the collaboration with the TriNetX network will help us reverse this trend in Finland for the benefit of patients suffering different kinds of devastating diseases.
  • TriNetX is the largest and fastest growing collaborative research network, representing healthcare organizations and health data partners across the world.
  • "We are excited to welcome FINBB to the TriNetX network," said Steve Lethbridge, Senior Vice President, Global Healthcare Partnerships at TriNetX.

BC Platforms Delivers on Global Real-World Data and Platform Access

Retrieved on: 
Friday, December 17, 2021

During 2021, BCP has successfully delivered significantly expanded global real-world data (RWD) and platform access in order to support precision medicine-led healthcare research and development (R&D).

Key Points: 
  • During 2021, BCP has successfully delivered significantly expanded global real-world data (RWD) and platform access in order to support precision medicine-led healthcare research and development (R&D).
  • The global footprint of the BC Platforms Data network has grown rapidly to now include RWD equivalent to approximately 25 million patient lives, including longitudinal clinical data in addition to 500k patients' genetic data, across 14 countries in Europe, North and South America, Asia and Africa.
  • BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine, accelerating the translation of insights into clinical practice.
  • Additionally, BC Platforms has developed a Global Data Partner Network BCRQUEST.com, which allows us to access more than 25 million patients across Europe, Americas, Africa, and Asiawith rich data for pharmaceutical and medical research and development.

BC Platforms Delivers on Global Real-World Data and Platform Access

Retrieved on: 
Friday, December 17, 2021

ZURICH, Dec. 17, 2021 /PRNewswire/ -- BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced a new clinical collaboration with the Colorado Center for Personalized Medicine (CCPM) and reported on its outstanding 2021 performance. Its new data partnership with the Colorado Center for Personalized Medicine (CCPM) will support the clinical translation of its basic research, including the potential to ensure improved and more personalized drug compatibility for patients. During 2021, BCP has successfully delivered significantly expanded global real-world data (RWD) and platform access in order to support precision medicine-led healthcare research and development (R&D). Leveraging its Data Network and the flagship BC|INSIGHT platform, which curates and analyses data in a secure format to advance personalized healthcare research, BCP has conducted impactful and transformational initiatives in key areas such as lung cancer, COVID-19, Duchenne muscular dystrophy and several others.

Key Points: 
  • During 2021, BCP has successfully delivered significantly expanded global real-world data (RWD) and platform access in order to support precision medicine-led healthcare research and development (R&D).
  • The global footprint of the BC Platforms Data network has grown rapidly to now include RWD equivalent to approximately 25 million patient lives, including longitudinal clinical data in addition to 500k patients' genetic data, across 14 countries in Europe, North and South America, Asia and Africa.
  • BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine, accelerating the translation of insights into clinical practice.
  • Additionally, BC Platforms has developed a Global Data Partner Network BCRQUEST.com, which allows us to access more than 25 million patients across Europe, Americas, Africa, and Asiawith rich data for pharmaceutical and medical research and development.

Finnforel to Invest EUR 45 Million in New Production Facilities and Build First Selective Breeding Centre for Rainbow Trout in Finland

Retrieved on: 
Tuesday, November 9, 2021

Finnforel is further expanding the production capacity of its Varkaus plant from one million to three million kilos.

Key Points: 
  • Finnforel is further expanding the production capacity of its Varkaus plant from one million to three million kilos.
  • Since the early 1990s, Natural Resources Institute Finland has carried out pioneering research in rainbow trout genetics, breeding and animal health.
  • Finnforel is financing these investments totalling EUR 45 million through a EUR 34 million share issue, EUR 4.5 million from the European Maritime and Fisheries Fund (EMFF) and EUR 6 million in loans from banks.
  • The company's best-known brand is Saimaan Tuore, whose rainbow trout products are available in more than a thousand grocery stores throughout Finland.

Master Patient Index Software Market Worth US$ 1,678.86 Million by 2028 at a CAGR of 10.3% Globally, COVID-19 Impact and Analysis by The Insight Partners

Retrieved on: 
Monday, September 20, 2021

Thus, there is a massive potential for the master patient index software market growth during the forecast period.

Key Points: 
  • Thus, there is a massive potential for the master patient index software market growth during the forecast period.
  • Based on type, the master patient index software market is bifurcated into service and software.
  • Get Sample Copy of Master Patient Index Software Market:
    Master Patient Index Software Market: Segmental Overview
    In terms of type, the master patient index software market is bifurcated into service and software.
  • Therefore, the COVID-19 pandemic is expected to impact the master patient index software market positively in the coming years.

Master Patient Index Software Market Worth US$ 1,678.86 Million by 2028 at a CAGR of 10.3% Globally, COVID-19 Impact and Analysis by The Insight Partners

Retrieved on: 
Monday, September 20, 2021

Thus, there is a massive potential for the master patient index software market growth during the forecast period.

Key Points: 
  • Thus, there is a massive potential for the master patient index software market growth during the forecast period.
  • Based on type, the master patient index software market is bifurcated into service and software.
  • Get Sample Copy of Master Patient Index Software Market:
    Master Patient Index Software Market: Segmental Overview
    In terms of type, the master patient index software market is bifurcated into service and software.
  • Therefore, the COVID-19 pandemic is expected to impact the master patient index software market positively in the coming years.